A genetic systemic disease: Clinical description of type 1 myotonic dystrophy in adults;Une maladie systémique génétique: Description clinique chez l'adulte de la dystrophie myotonique de type 1

Revue de Medecine Interne

Volumn 33, Issue 9, 2012, Pages 514-518

  Kaminsky, P ^a   Pruna, L ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Cardiopathy; Cataract; Endocrinological disorders; Hypogammaglobulinemia; Metabolic disorders; Myotonic dystrophy; Restrictive lung disease; Sleep disorders

Indexed keywords

MESSENGER RNA; MYOTONIC DYSTROPHY PROTEIN KINASE;

3' UNTRANSLATED REGION; BIOGENESIS; CANCER INCIDENCE; CATARACT; CLINICAL FEATURE; EXON; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GLUCOSE INTOLERANCE; GONADAL DISEASE; HUMAN; HYPERPARATHYROIDISM; IMMUNOGLOBULIN DEFICIENCY; LIFE EXPECTANCY; METABOLIC SYNDROME X; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY PROTEIN KINASE GENE; PROGNOSIS; SHORT SURVEY; SYSTEMIC DISEASE; TRINUCLEOTIDE REPEAT;

ADULT; ENDOCRINE SYSTEM DISEASES; EYE DISEASES; HEART DISEASES; HUMANS; MUSCLE, SKELETAL; MYOTONIA; MYOTONIC DYSTROPHY; NEOPLASMS; NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT DISEASES;

EID: 84868269948     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.03.355     Document Type: Short Survey

References (51)

1. Fu Y.H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
2. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255:1253-1255.
3. Osborne R.J., Lin X., Welle S., Sobczak K., O'Rourke J.R., Swanson M.S., et al. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 2009, 18:1471-1481.
4. Harper P.S., Monckton D.G. Myotonic dystrophy. Myology basic and clinical 2005, 1039-1076. Mac Graw-Hill, New York. 3rd ed. A.G. Engel, C. Franzini-Amstrong (Eds.).
5. Begin P., Mathieu J., Almirall J., Grassino A. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 1997, 156:133-139.
6. Begin R., Bureau M.A., Lupien L., Bernier J.P., Lemieux B. Pathogenesis of respiratory insufficiency in myotonic dystrophy: the mechanical factors. Am Rev Respir Dis 1982, 125:312-318.
7. Jammes Y., Pouget J., Grimaud C., Serratrice G. Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve 1985, 8:586-594.
8. Gilmartin J.J., Cooper B.G., Griffiths C.J., Walls T.J., Veale D., Stone T.N., et al. Breathing during sleep in patients with myotonic dystrophy and non-myotonic respiratory muscle weakness. Q J Med 1991, 78:21-31.
9. Kiyan E., Okumus G., Cuhadaroglu C., Deymeer F. Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 2010, 14:19-24.
10. Zifko U.A., Hahn A.F., Remtulla H., George C.F., Wihlidal W., Bolton C.F. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain 1996, 119:1911-1922.
11. Kaminsky P., Poussel M., Pruna L., Deibener J., Chenuel B., Brembilla-Perrot B. Organ involvements and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) 2011, 90:262-268.
12. de Backer M., Bergmann P., Perissino A., Gottignies P., Kahn R.J. Respiratory failure and cardiac disturbances in myotonic dystrophy. Eur J Intensive Care Med 1976, 2:63-67.
13. Mathieu J., Allard P., Potvin L., Prevost C., Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999, 52:1658-1662.
14. Sovari A.A., Bodine C.K., Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiol Rev 2007, 15:191-194.
15. Melacini P., Villanova C., Menegazzo E., Novelli G., Danieli G., Rizzoli G., et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995, 25:239-245.
16. Bhakta D., Lowe M.R., Groh W.J. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004, 147:224-227.
17. Nguyen H.H., Wolfe J.T., Holmes D.R., Edwards W.D. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988, 11:662-671.
18. Phillips M.F., Harper P.S. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997, 33:13-22.
19. Lazarus A., Varin J., Babuty D., Anselme F., Coste J., Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002, 40:1645-1652.
20. Segawa I., Kikuchi M., Tashiro A., Hiramori K., Sato M., Satodate R. Association of myotonic dystrophy and sick sinus syndrome, with special reference to electrophysiological and histological examinations. Intern Med 1996, 35:185-188.
21. Brembilla-Perrot B., Luporsi J.D., Louis S., Kaminsky P. Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary. Europace 2011, 13:251-257.
22. Laurent V., Pellieux S., Corcia P., Magro P., Pierre B., Fauchier L., et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2011, 150:54-58.
23. Groh W.J., Groh M.R., Saha C., Kincaid J.C., Simmons Z., Ciafaloni E., et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008, 358:2688-2697.
24. Finsterer J., Stollberger C. Atrial fibrillation/flutter in myopathies. Int J Cardiol 2008, 128:304-310.
25. Halawa A., Iskandar S.B., Brahmbhatt V., Fahrig S.A. Atrial flutter and myotonic dystrophy in a male adolescent treated with radiofrequency catheter ablation. Rev Cardiovasc Med 2007, 8:118-122.
26. Kaminsky P., Brembilla-Perrot B., Pruna L., Poussel M., Chenuel B. Age, conduction defects and restrictive lung disease independently predict cardiac events and death in myotonic dystrophy. Int J Cardiol 2011, 10.1016/j.ijcard.2011.05.070.
27. Morrone A., Pegoraro E., Angelini C., Zammarchi E., Marconi G., Hoffman E.P. RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J Clin Invest 1997, 99:1691-1698.
28. Guiraud-Dogan C., Huguet A., Gomes-Pereira M., Brisson E., Bassez G., Junien C., et al. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice. Biochim Biophys Acta 2007, 1772:1183-1191.
29. Perseghin G., Caumo A., Arcelloni C., Benedini S., Lanzi R., Pagliato E., et al. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 2003, 26:2112-2118.
30. Matsumura T., Iwahashi H., Funahashi T., Takahashi M.P., Saito T., Yasui K., et al. A cross-sectional study for glucose intolerance of myotonic dystrophy. J Neurol Sci 2009, 276:60-65.
31. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., et al. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 2004, 101:7088-7093.
32. Pruna L., Chatelin J., Pascal-Vigneron V., Kaminsky P. Body composition in myotonic dystrophy. Muscle Nerve 2011, 10.1002/mus.22099.
33. Yoshida H., Oshima H., Saito E., Kinoshita M. Hyperparathyroidism in patients with myotonic dystrophy. J Clin Endocrinol Metab 1988, 67:488-492.
34. Mastrogiacomo I., Bonanni G., Menegazzo E., Santarossa C., Pagani E., Gennarelli M., et al. Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy. Ital J Neurol Sci 1996, 17:59-65.
35. Abe T., Sato M., Kuboki J., Kano T., Tamai M. Lens epithelial changes and mutated gene expression in patients with myotonic dystrophy. Br J Ophthalmol 1999, 83:452-457.
36. Ashizawa T., Hejtmancik J.F., Liu J., Perryman M.B., Epstein H.F., Koch D.D. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet 1992, 42:55-60.
37. Kimizuka Y., Kiyosawa M., Tamai M., Takase S. Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation. Retina 1993, 13:129-135.
38. Kaminsky P., Lesesve J.F., Jonveaux P., Pruna L. IgG deficiency and expansion of CTG repeats in myotonic dystrophy. Clin Neurol Neurosurg 2011, 113:464-468.
39. Wochner R.D., Drews G., Strober W., Waldmann T.A. Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest 1966, 45:321-329.
40. Kim J., Hayton W.L., Robinson J.M., Anderson C.L. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol 2007, 122:146-155.
41. Rudnik-Schoneborn S., Zerres K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004, 114:44-53.
42. Van Spaendonck K.P., Ter Bruggen J.P., Weyn Banningh E.W., Maassen B.A., Van de Biezenbos J.B., Gabreels F.J. Cognitive function in early adult and adult onset myotonic dystrophy. Acta Neurol Scand 1995, 91:456-461.
43. Modoni A., Silvestri G., Vita M.G., Quaranta D., Tonali P.A., Marra C. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study. J Neurol 2008, 255:1737-1742.
44. Winblad S., Lindberg C., Hansen S. Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2006, 2:16.
45. Abe K., Fujimura H., Toyooka K., Yorifuji S., Nishikawa Y., Hazama T., et al. Involvement of the central nervous system in myotonic dystrophy. J Neurol Sci 1994, 127:179-185.
46. Kuo H.C., Hsieh Y.C., Wang H.M., Chuang W.L., Huang C.C. Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1. Acta Neurol Scand 2008, 117:101-107.
47. Damian M.S., Gerlach A., Schmidt F., Lehmann E., Reichmann H. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001, 56:794-796.
48. Gibbs J.W., Ciafaloni E., Radtke R.A. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 2002, 25:662-665.
49. Talbot K., Stradling J., Crosby J., Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 2003, 13:357-364.
50. Delfino M., Monfrecola G., Ayala F., Suppa F., Piccirillo A. Multiple familial pilomatricomas: a cutaneous marker for myotonic dystrophy. Dermatologica 1985, 170:128-132.
51. Mueller C.M., Hilbert J.E., Martens W., Thornton C.A., Moxley R.T., Greene M.H. Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control 2009, 20:2009-2020.